Insulin degludec, insulin aspart drug combination
Showing 1 - 25 of >10,000
Diabetes Trial (Insulin Degludec and Insulin Aspart)
Not yet recruiting
- Diabetes
- Insulin Degludec and Insulin Aspart
- (no location specified)
Apr 4, 2023
Type 2 Diabetes Trial in China (Insulin Degludec and Insulin Aspart Injection, Insulin Aspart Injection)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Insulin Degludec and Insulin Aspart Injection
- Insulin Aspart Injection
-
Shijiazhuang, Hebei, China
- +5 more
Jun 13, 2022
Diabetes, Type 1, Diabetes, Type 2 Trial in China (Faster aspart, Insulin aspart, Insulin degludec)
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Faster aspart
- +2 more
-
Hefei, Anhui, China
- +34 more
Nov 3, 2022
Liver Cirrhosis, Diabetes Trial in Shanghai (Insulin Degludec and Insulin Aspart)
Recruiting
- Liver Cirrhosis
- Diabetes
- Insulin Degludec and Insulin Aspart
-
Shanghai, Shanghai, ChinaXiaolong Zhao
Nov 29, 2022
Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)
Recruiting
- Diabetes Mellitus, Type 2 Treated With Insulin
- insulin degludec + liraglutide
- Insulin Glargine - Insulin Aspart
-
Bogotá, ColombiaHospital Universitario San Ignacio
Mar 2, 2023
Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- insulin icodec
- +2 more
-
Concord, California
- +98 more
Feb 2, 2023
Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)
Recruiting
- Diabetes Mellitus
- Diabetic Kidney Disease
- Dulaglutide
- +2 more
-
Sha Tin, Hong KongPrince of Wales Hospital
Nov 8, 2022
Type 1 Diabetes Trial in Loma Linda, Austin (Afrezza (insulin human) Inhalation Powder, insulin degludec, Continuous
Recruiting
- Type 1 Diabetes
- Afrezza (insulin human) Inhalation Powder
- +2 more
-
Loma Linda, California
- +1 more
Apr 12, 2022
Type 1 Diabetes Trial in Aurora (Multiple daily ijnection using Insulin Degludec and Insulin Aspart)
Completed
- Type 1 Diabetes
- Multiple daily ijnection using Insulin Degludec and Insulin Aspart
-
Aurora, ColoradoBarbara Davis Center for Diabetes
Sep 9, 2021
Type 1 Diabetes With Diabetic Gastroparesis, HbA1c, Time in Range Trial in Hangzhou (insulin degludec/insulin aspart (IDegAsp),
Recruiting
- Type 1 Diabetes Mellitus With Diabetic Gastroparesis
- +2 more
- insulin degludec/insulin aspart (IDegAsp)
- basal insulin plus pre-prandial insulin
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jul 7, 2021
Diabetes, Diabetes, Type 1 Trial in Worldwide (Insulin degludec, Insulin Aspart, Insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Insulin degludec
- +2 more
-
Caba, Argentina
- +70 more
Mar 29, 2022
Type1 Diabetes Trial in Asheville (Aspart)
Completed
- Type1 Diabetes Mellitus
-
Asheville, North CarolinaMountain Diabetes and Endocrine Center
Feb 23, 2021
NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects Blood
Enrolling by invitation
- Diabetes Mellitus, Type 1
- Insulin degludec
- Fast-acting insulin aspart
-
Bonheiden, Belgium
- +22 more
Dec 19, 2022
Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo insulin icodec, Insulin degludec)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
- +3 more
-
Guntersville, Alabama
- +91 more
Nov 11, 2022
Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)
Completed
- Type 2 Diabetes Mellitus
- INSULIN GLARGINE (HOE901)
- +5 more
-
China, ChinaCHINA
Apr 21, 2022
Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Insulin Degludec/Insulin Aspart
-
Beirut, Hamra, Beirut, LebanonNovo Nordisk Investigational Site
Sep 30, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +3 more
-
Concord, California
- +166 more
Jan 6, 2022
Type 1 Diabetes Trial in Argentina, China, Mexico (LY900014, Insulin Lispro, Insulin Glargine)
Completed
- Type 1 Diabetes Mellitus
- LY900014
- +3 more
-
Caba, Buenos Aires, Argentina
- +29 more
Feb 18, 2022
(rPMS) Study of Ryzodeg® FlexTouch® to Evaluate Safety and
Completed
- Diabetes
- +2 more
- Insulin degludec /insulin aspart
-
Busan, Korea, Republic of
- +26 more
Nov 9, 2021